Literature DB >> 19214924

Relationships between glucose variability and conventional measures of glycemic control in continuously monitored patients with type 2 diabetes.

K-D Kohnert1, L Vogt, P Augstein, P Heinke, E Zander, K Peterson, E-J Freyse, E Salzsieder.   

Abstract

Given the importance of glucose variability in the development of diabetic complications, the present study used continuous glucose monitoring (CGM) to determine various indices of glucose variability and to investigate their relationships with conventional measures of chronic sustained hyperglycemia. We examined 53 women and 61 men, aged 36-79 years afflicted with type 2 diabetes for 1-24 years. The following indices of glycemic variability were computed from CGM data sets: mean amplitude of glycemic excursions (MAGE), CGM glucose range, interquartile range (IQR), SD-score, and average daily risk range (ADRR). CGM measurements and self-monitored blood glucose (SMBG) records were used to calculate mean CGM sensor glucose and mean SMBG, respectively. In simple correlation analysis, the indices of glucose variability showed weak correlations with HbA1c: MAGE (r=0.27, p <0.01), CGM glucose range (r=0.21, p <0.05), IQR (r=0.31, p <0.01), SD-score (r=0.34, p<0.001), and ADRR (r=0.24, p<0.05). These indices were found to differ at identical HbA1c among several patients, as reflected by diurnal excursions of different frequency and magnitude. With the exception of ADRR, stronger correlations were found between mean SMBG and the other variability indices (r=0.51-0.63, p<0.01 for all). CGM provides various indices of glycemic variability not captured by conventional measures of glycemic control. Detection of the location and the magnitude of glucose fluctuations by CGM should aid in optimal treatment of glycemic disorders in type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19214924     DOI: 10.1055/s-0028-1128143

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  10 in total

Review 1.  Average daily risk range as a measure for clinical research and routine care.

Authors:  Susana R Patton; Mark A Clements
Journal:  J Diabetes Sci Technol       Date:  2013-09-01

Review 2.  Metrics Beyond Hemoglobin A1C in Diabetes Management: Time in Range, Hypoglycemia, and Other Parameters.

Authors:  Lorena Alarcon-Casas Wright; Irl B Hirsch
Journal:  Diabetes Technol Ther       Date:  2017-05       Impact factor: 6.118

Review 3.  Utility of different glycemic control metrics for optimizing management of diabetes.

Authors:  Klaus-Dieter Kohnert; Peter Heinke; Lutz Vogt; Eckhard Salzsieder
Journal:  World J Diabetes       Date:  2015-02-15

Review 4.  Therapeutics of diabetes mellitus: focus on insulin analogues and insulin pumps.

Authors:  Vasiliki Valla
Journal:  Exp Diabetes Res       Date:  2010-05-26

5.  Average Daily Risk Range (ADRR) in Young Children With Type 1 Diabetes.

Authors:  Maureen Monaghan; Tamiko B Younge; Robert McCarter; Fran R Cogen; Randi Streisand
Journal:  J Diabetes Sci Technol       Date:  2014-01-01

6.  Successful implementation of a perioperative glycemic control protocol in cardiac surgery: barrier analysis and intervention using lean six sigma.

Authors:  Elizabeth A Martinez; Raul Chavez-Valdez; Natalie F Holt; Kelly L Grogan; Katherine W Khalifeh; Tammy Slater; Laura E Winner; Jennifer Moyer; Christoph U Lehmann
Journal:  Anesthesiol Res Pract       Date:  2011-09-06

7.  Patient-Tailored Decision Support System Improves Short- and Long-Term Glycemic Control in Type 2 Diabetes.

Authors:  Petra Augstein; Peter Heinke; Lutz Vogt; Klaus-Dieter Kohnert; Eckhard Salzsieder
Journal:  J Diabetes Sci Technol       Date:  2021-05-18

Review 8.  Type 2 Diabetes and Glycemic Variability: Various Parameters in Clinical Practice.

Authors:  Masaya Sakamoto
Journal:  J Clin Med Res       Date:  2018-09-10

9.  Sodium Glucose Cotransporter-2 Inhibitor Protects Against Diabetic Neuropathy and Nephropathy in Modestly Controlled Type 2 Diabetes: Follow-Up Study.

Authors:  Fukashi Ishibashi; Aiko Kosaka; Mitra Tavakoli
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-17       Impact factor: 6.055

Review 10.  CGMS and Glycemic Variability, Relevance in Clinical Research to Evaluate Interventions in T2D, a Literature Review.

Authors:  Anne-Esther Breyton; Stéphanie Lambert-Porcheron; Martine Laville; Sophie Vinoy; Julie-Anne Nazare
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-09       Impact factor: 5.555

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.